US FDA approves Genmab-AbbVie’s blood cancer therapy


The United States Food and Drug Administration (FDA) has approved AbbVie Inc and Danish drugmaker Genmab’s blood cancer therapy for adult patients who have received at least two prior lines of treatment, the companies said Friday, May 19. The therapy, epcoritamab, which will be sold under the brand name Epkinly, treats a type of advanced […]

The post US FDA approves Genmab-AbbVie’s blood cancer therapy appeared first on Inquirer Technology.

Read more at : inquirer

Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.